U.S. companies are holding $2.6 trillion in cash overseas, according to new research.
In the 2017 CNBC Stock Draft, The Rugters All-Stars choose their second-round draft pick.
Rather than use the money for hiring and capital purchases, companies plowed the cash into buybacks and dividends.
Samsung Bioepis has won regulatory approval for key biosimilar drug, the first time the company's product has been approved for U.S. use.
South Korea's Samsung Bioepis wins U.S. FDA nod for biosimilar of J&J's Remicade.
The U.S. Food and Drug Administration approved Renflexis, developed by Samsung Bioepis Co. of South Korea. Its U.S. partner, Merck& Co. of Kenilworth, New Jersey, will market Renflexis. The first biosimilar for Remicade, Inflectra from New York- based Pfizer Inc., went on sale in November at a 15 percent discount.
This Saturday's March for Science is trying hard to be a nonpartisan event, but some may not see it that way.
The bank's global M&A boss dangled the audacious notion that capital markets could fully finance a 12-figure takeover.
The company had received grand jury subpoenas from the U.S. Justice Department amid an antitrust investigation.
Increased pressure to cut medicine prices and an industry-wide slowdown in consumer health product sales is hurting health care giant Johnson& Johnson. The world's biggest maker of health care products cited its pending $30 billion purchase of biopharmaceutical company Actelion for the raised forecast. The New Brunswick, New Jersey- based company on...
LITTLE ROCK, Ark.— The U.S. Supreme Court blocked Arkansas from beginning a series of executions Monday. Midazolam is the key drug in the procedure and one that Arkansas hasn't yet used in an execution. Because the state's supply reaches its expiration date April 30, Arkansas scheduled eight executions before then.
CNBC's Meg Tirrell takes a look at the next potential blockbuster drugs. With the "Fast Money" traders.
Doctors carve from hip to hip, slicing off skin, tightening muscles, tugging at innards. Patients often need strong painkillers for days or even weeks, but Mary Hernandez went home on just over-the-counter ibuprofen. The Houston woman was helping test a novel medicine aimed at avoiding opioids, potent pain relievers fueling an epidemic of overuse and addiction.
President Donald Trump plans to revive the hobbled Export-Import Bank of the United States, his office said.
Mylan announced Friday that it is expanding its voluntary EpiPen recall to include units in the United States.
Jim Cramer surveyed the consumer products space to find which stocks could satiate your portfolio’s appetite.
Jim Cramer rattled off his take on caller favorite stocks, including defense contractor Raytheon.
Hospital-related stocks started the week in the green following the failure of the GOP's effort to replace Obamacare.
Managed care and drug stocks will be ones to watch, now that the GOP's health-care bill has been stopped.
The "Fast Money" traders share their first moves for St. Patrick's Day.